BPO 0.00% 0.3¢ bioprospect limited

best news bioprospect, page-5

  1. 6,187 Posts.
    lightbulb Created with Sketch. 497
    One nice little detail is the pick-up of the Chinese rights from Nova Vita. On top of the European, USA & Canada rights.
    Revenue targets $5-7.5 mil PA by 2010 - and thats on top of Termilone revenues kicking in 2008-2009.
 
watchlist Created with Sketch. Add BPO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.